Showing 1,541 - 1,560 results of 226,311 for search '(( 10 ((nn decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (a decrease)) ))', query time: 2.05s Refine Results
  1. 1541
  2. 1542
  3. 1543
  4. 1544
  5. 1545
  6. 1546

    mFIZZ1′ and mFIZZ1 decreased the IL-13 and IL-5 secretion of splenocytes. by Wael Gad (285901)

    Published 2013
    “…Recombinant mFIZZ1′ and mFIZZ1 expressed with or without hQSOX1b were used at 200 ng/ml. rRa is the bacterial recombinant FIZZ1 (200 ng/ml) from (Peprotech) and PBS is the control. (<b>A</b>) Recombinant mFIZZ1′ and mFIZZ1 co-expressed with hQSOX1b significantly decreased the IL-5 secretion compared to the proteins expressed alone. …”
  7. 1547
  8. 1548

    Heart rate variability in type 2 diabetes mellitus: A systematic review and meta–analysis by Thomas Benichou (5047928)

    Published 2018
    “…Levels of blood glucose and HbA1c were associated with several HRV parameters, as well as Time from diagnosis of T2DM</p><p>Conclusions</p><p>T2DM was associated with an overall decrease in the HRV of T2DM patients. …”
  9. 1549

    Decreased expression of adipogenesis-related genes by baicalein in early stage of adipogenesis. by Yukari Nakao (3138795)

    Published 2016
    “…**<i>p</i><0.01, as indicated by the brackets. B, Decrease in glucose uptake in 3T3-L1 cells by baicalein. …”
  10. 1550
  11. 1551
  12. 1552
  13. 1553

    Transforming growth factor (TGF)-β1 induced a robust decrease in S-phase in non-cancer cell strains by Kimberly A Brown (26546)

    Published 2011
    “…Representative histograms are presented illustrating cells that had a robust decrease in S-phase (NMuMG), modest decrease in S-phase (EpH4), and no decrease in S-phase (MDA-MB-436) as a result of TGF-βtreatment. …”
  14. 1554
  15. 1555
  16. 1556
  17. 1557
  18. 1558
  19. 1559
  20. 1560